CollPlant sets up 3D organ bio-printing unit

CollPlant Bio-Ink Photo: PR

The Israeli regenerative medicine company's bio-ink is intended for use in 3D printers that print organs and tissues using various printing technologies.

Israeli regenerative medicine company CollPlant Holdings Ltd. (TASE: CLPT) has set up a division that will focus on the further development of a collagen-based biological ink. CollPlant’s BioInk is intended for use in 3D printers that print organs and tissues using various printing technologies.

CollPlant CEO Yehiel Tal said, “Over the last several months, we have substantially ramped up our activities in the 3D printing field leveraging biological ink that we are developing based on our rhCollagen technology. The collagen protein is a keyattached also building block in connective tissues in the human body, and therefore is ideal for use as biological ink. In particular, our rhCollagen is especially suitable for use in humans, due to its superior homogeneity, its high safety profile and the fact that it does not cause an immunological reaction. We are currently developing a number of formulations of biological ink for various indications, and are working with several large international companies, with the aim of collaborating in the development of organs and tissues printing.”

According to the US Department of Health and Human Services, the number of people in the United States waiting for a transplant of a critical, life-saving organ such as a kidney, liver or pancreas, is approximately 118,000, and the organ transplant waiting list grows every year. BioInk is a significant component of the burgeoning 3D bioprinting market, which is expected to grow to approximately $1.8 billion by 2022, and to increase substantially as the printing technology, and all its components, continue to mature.

Published by Globes [online], Israel business news - www.globes-online.com - on May 14, 2017

© Copyright of Globes Publisher Itonut (1983) Ltd. 2017

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
CollPlant Bio-Ink Photo: PR
CollPlant Bio-Ink Photo: PR
Twitter Facebook Linkedin RSS Newsletters גלובס Capital  Markets Conference 2017